Companies · Hospitals and Physicians
NEW YORK · Hospitals and Physicians
Diligence memoA one-page analyst read on U S HealthVest, LLC — recommendation, valuation, rhythm, risks.→U S HealthVest, LLC has raised $125M over 6 rounds; too few niche peers to rank its valuation yet.
Synthesized from the figures below est. — every claim rests on a number shown on this page. Valuation uses the health services sector profile.
Analyst read est. — computed against this company's niche peers in the same era. Inputs shown; not a quoted figure.
Procedural diagnosis est. — rule-based common-sense checks over the filing pattern, issuer name, activity cadence, and surfaced operating evidence.
U S HealthVest, LLC behaves more like a recurring private-offering issuer than a conventional venture-backed operating company.
No named principal in this company's public records yet — see all operators below.
Explore how these operators interlock with other companies in the operator network.
U S HealthVest, LLC is one of 599 Hospitals and Physicians companies tracked from NEW YORK. By capital raised it ranks among the largest (ahead of 97% of sector peers), and among the largest by modeled valuation est..
Ranking is computed against this company's own sector cohort — reported capital is fact; valuation tiers are modeled.
As reported in public records reported — not modeled.
Solid bars are reported offering amounts reported; hatched bars are the modeled post-money valuation est. — both on one shared scale so you can read raise-vs-worth at each round directly. Use the toggles to overlay data labels and the niche-peer / market average value lines.
The line shows cumulative reported funding over the period; + labels show new capital added between points when there is room. Toggle on-bar figures, plus the niche-peer and market averages, to read this company against its cohort. Benchmarks are modeled medians.
Stages are modeled from round size (public records carry no series label). No record for: Pre-Seed, Seed, Series A — the company may have raised it under a different exemption, merged it into an adjacent record, or skipped it. Sequence completeness: 40%.
Round size and date are reported; the stage label is inferred from round size (latest is Series C — a $40M–$100M round). Valuation is modeled from stage benchmarks scaled by the health services sector profile. Directional, not a quoted figure.
Benchmarked against 599 companies in Hospitals and Physicians. Each bar is a median (the middle company, not an average — outliers don't skew it). Two yardsticks: real money raised (reported on Form D) and modeled value (our estimate est.). These are whole-sector medians across all stages, except the per-stage row.
Raised more than 97% of sector peers (real $). Modeled value above 90% of peers (estimate).
A tighter cohort than the sector chart above — only companies at the same stage (Series C) that last raised in the same ~3-year era, ranked by modeled value est. (not money raised). This is the exact set the analyst read compares against, so a like-for-like cohort is what makes "over/under-valued" meaningful.
| Company | Stage | Raised · real | Value · est | vs peer med. |
|---|---|---|---|---|
| ACM Holdco, LP | Series C | $100.0M | $2.1B | 1.50× |
| Premier Imaging Holdings, LLC | Series C | $86.7M | $1.8B | 1.30× |
| Kentucky Hospital Management LLC | Series C | $46.4M | $986.7M | 0.70× |
| U S HealthVest, LLC this company | Series C | $125.3M | $212.6M | 0.15× |
Stage is inferred from round size est., not reported on the filing — a round's dollar size maps to a bucket: Pre-Seed <$1.0M · Seed $1.0M–$4.0M · Series A $4.0M–$15M · Series B $15M–$40M · Series C $40M–$100M · Series D+ $100M–$400M · Growth/Late >$400M.
| Stage | Amount · real | Announced | Post-money · est | Value · est | Conf. |
|---|---|---|---|---|---|
| Series B | $36.3M | 2013-03-01 | $201.4M | $746.8M | 85% |
| Series B | $10.0M | 2015-04-13 | $55.6M | $206.0M | 85% |
| Series B | $9.0M | 2016-05-13 | $50.0M | $185.4M | 85% |
| Series C | $50.0M | 2016-06-17 | $333.3M | $1.1B | 85% |
| Series C | $10.0M | 2018-04-26 | $66.7M | $212.6M | 90% |
| Series C | $10.0M | 2018-11-20 | $66.7M | $212.6M | 90% |
Step-up, pace versus the sector's normal cadence, and revenue/exemption moves — read straight from the reported round facts reported.
Predictive signals are modeled est. from this company's own cadence and step-up, plus sector benchmarks — directional, not advice. Peer set and a CSV export live in your analyst workspace.
Officers, directors and promoters named in this company's public recordsreported — the people who run it (not its investors). "Also runs" counts come from name-matching across all records, so verify before acting.
| Person | Role | Also runs | Tied since |
|---|---|---|---|
| Andrew Adams | — | 12 other | 2016-06 |
| Brian Chee | — | 9 other | 2013-03 |
| Jonathan Lim | — | 8 other | 2016-05 |
| Jon Lim | — | 8 other | 2015-04 |
| Richard Kresch | — | 2 other | 2013-03 |
| James Cha | — | 1 other | 2015-04 |
| Neal Cury | — | — | 2015-04 |
U S HealthVest, LLC is an official record sourced from the U.S. Securities and Exchange Commission (SEC). U.S. data is aggregated from SEC Form D filings.
Nearest neighbours across the whole database — matched on sector, stage and capital scale, and on shared operators (officers or directors named at both companies in public filings). A discovery shortlist, not a valuation cohort — verify before acting, the same way modeled figures are directional.
| Company | Sector | Stage | Raised · real | Value · est | Why similar |
|---|---|---|---|---|---|
| Lola Development, LLC | Hospitals and Physicians | Series A | $6.7M | $125.1M | network3 shared operators · same sector |
| DMG Practice Management Solutions LLC | Hospitals and Physicians | Series C | $99.8M | $351.9M | same sector · same stage |
| Ignyta, Inc. | Biotechnology | Series C | $113.6M | $1.2B | network1 shared operator · same stage |
| Advantia Holdings LLC | Hospitals and Physicians | Series C | $212.1M | $33.6M | same sector · same stage |
| TherapyMatch, Inc. | Other Health Care | Series C | $100.0M | $809.2M | network1 shared operator · same stage |
| Equip Health, Inc. | Healthtech | Series C | $163.8M | $343.5M | network1 shared operator · same stage |
| Akido Labs, Inc. | AI / ML | Series C | $84.3M | $676.4M | network1 shared operator · same stage |
| Avanti Medical Group | Hospitals and Physicians | Series C | $50.0M | $254.8M | same sector · same stage |
Matched by meaning, not labels — a local language model reads each company's name, sector and description and ranks the closest in that learned space. This catches look-alikes that cross sector boundaries; the structured list above explains its matches, this one trusts the text. Directional, like every modeled signal here.
| Company | Sector | Stage | Value · est | Match |
|---|---|---|---|---|
| VitalSkin Holdings, LLC | Hospitals and Physicians | Pre-Seed | $9.2M | 81% |
| Usc, Llc | Hospitals and Physicians | Pre-Seed | $4.9M | 81% |
| Total Health Centers LLC | Hospitals and Physicians | Pre-Seed | $555K | 80% |
| Sdg Holding Company, Llc | Hospitals and Physicians | Series D+ | $30.5M | 80% |
| Fortress Health Partners, LLC | Hospitals and Physicians | Series A | $143.5M | 80% |
| Derm Holdings LLC | Hospitals and Physicians | Series C | $1.0B | 79% |
| MHP Consolidated LLC | Hospitals and Physicians | Series B | $85.4M | 79% |
| AndHealth LLC | Hospitals and Physicians | Series A | $50.0M | 79% |
See where U S HealthVest, LLC sits in the wider market — its sector, location and stage cohorts, each with their own leaderboards and capital-flow timelines.
If you work at U S HealthVest, LLC, claim this profile or suggest a correction. We aggregate from public filings, so help us keep your description, website and links accurate.
Is this your company? Update your profile or add contact details — and choose exactly who can reach you. Reviewed before anything is published.